P3 Health PartnersPIII -9.50%47 EV-to-FCF is -4.03 as of Jul. 06, 2026. GuruFocus rates PIII with a GF Score™ of 47/100 and a GF Value™ of $9.22 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 404 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 247524.5% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, P3 Health Partners's Enterprise Value is $343 Mil.
P3 Health Partners's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-85 Mil. Therefore, P3 Health Partners's EV-to-FCF for today is -4.03.
The historical rank and industry rank for P3 Health Partners's EV-to-FCF or its related term are showing as below:
PIII'
s EV-to-FCF Range Over the Past 10 Years
Min: -48.04 Med: -5.64 Max: -1.67
Current: -4.03
During the past 8 years, the highest EV-to-FCF of P3 Health Partners was -1.67. The lowest was -48.04. And the median was -5.64.
PIII's EV-to-FCF is ranked worse than 100% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 17.75
vs PIII: -4.03
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
P3 Health Partners (NAS:PIII) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
P3 Health Partners's PE Ratio (TTM) for today is calculated as:
P3 Health Partners's share price for today is $10.29.
P3 Health Partners's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-38.600.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
P3 Health Partners EV-to-FCF Related Terms
P3 Health Partners EV-to-FCF Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, P3 Health Partners's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's EV-to-FCF falls into.
P3 Health Partners's current Enterprise Value is $343 Mil.
P3 Health Partners's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (PIII) has a EV-to-FCF of -4.03 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #999999 out of 404 companies in the Healthcare Providers & Services industry.
Is P3 Health Partners' EV-to-FCF too high?
P3 Health Partners' current EV-to-FCF is -4.03. Based on the distribution chart, P3 Health Partners ranks #999999 out of 404 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' EV-to-FCF compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #999999 out of 404 companies for EV-to-FCF. This places P3 Health Partners in the lower half of its industry. The industry median EV-to-FCF is 17.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.75, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current EV-to-FCF is -4.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.22, compared to a current price of $10.29 — trading 11.6% above its estimated fair value. The current EV-to-FCF is -4.03. P3 Health Partners' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For P3 Health Partners (PIII), the current EV-to-FCF is -4.03 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.29 is trading 11.6% above its estimated GF Value™ of $9.22.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
EV-to-FCF: -4.03
GF Value™: $9.22 vs. price of $10.29 (11.6% above fair value)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
47GF Score
Get the complete analysis for PIII
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 
